Home▸Articles▸Psilocybin/MDMA-Assisted Therapy

Psychedelic Therapy Contraindication Screening: Ensuring Patient Safety

Understanding the contraindications is crucial for the safe and effective use of psychedelic therapies in mental health treatment.

mysimulator teamUpdated June 2026≈ 3 min read▶ Open the simulation

What Contraindications Are

Contraindications refer to conditions or factors that make a particular treatment unsuitable or potentially harmful. In the context of psychedelic therapies, contraindications include medical and psychiatric conditions such as severe anxiety, depression, psychosis, or a history of substance abuse.

Screening for these contraindications is essential to prevent adverse effects and ensure the patient's safety during therapy.

Why It Matters

Identifying contraindications before starting psychedelic therapy can significantly reduce the risk of complications, such as exacerbation of mental health issues or physical harm. Ensuring that patients are suitable for treatment also enhances the therapeutic outcomes and patient satisfaction.

Contraindication screening is a critical step in the preparation process, allowing healthcare providers to tailor the therapy to individual needs and monitor the patient closely during and after the session.

live demo · related simulation● LIVE

Common Contraindications

Some common contraindications for psychedelic therapies include active substance use disorders, severe psychiatric conditions like schizophrenia or bipolar disorder, untreated depression, and certain cardiac conditions. Patients with a history of trauma or dissociative disorders may also be at higher risk.

Healthcare providers must carefully evaluate each patient's medical and psychological history to determine their suitability for treatment.

Screening Process

The screening process typically involves a thorough assessment of the patient’s medical history, current medications, and mental health status. This may include interviews, questionnaires, and sometimes physical examinations or laboratory tests.

Healthcare providers use this information to identify any potential contraindications that could pose risks during psychedelic therapy.

Frequently asked questions

What are the most common reasons for contraindication in psychedelic therapy?

Common reasons include active substance use disorders, severe psychiatric conditions like schizophrenia or bipolar disorder, untreated depression, and certain cardiac conditions.

How does screening help ensure patient safety during psychedelic therapy?

Screening helps identify potential risks that could lead to adverse effects, allowing healthcare providers to take necessary precautions and tailor the treatment plan accordingly.

Can someone with a history of trauma or dissociative disorders still undergo psychedelic therapy?

It depends on the severity and current state of their condition. Healthcare providers will assess each case individually to determine if they are suitable for treatment.

What happens if a contraindication is identified during screening?

If a contraindication is found, the patient may be referred to other treatments or given recommendations on how to address their condition before considering psychedelic therapy.

Try it live

Everything above runs in your browser — open Psychedelic Therapy Contraindication Screening Simulator and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.

▶ Open Psychedelic Therapy Contraindication Screening Simulator simulation

What did you find?

Add reproduction steps (optional)